Metronidazole Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244846

Publication Date:

November 12, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Metronidazole Injection is a sterile, parenteral dosage form of metronidazole in water. Metronidazole is classified as a synthetic antibacterial and antiprotozoal agent and is administered by the intravenous route. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Metronidazole Injection and other antibacterial drugs, Metronidazole Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection.
The global market for Metronidazole Injection was estimated to be worth US$ 32 million in 2023 and is forecast to a readjusted size of US$ 30 million by 2030 with a CAGR of -1.2% during the forecast period 2024-2030
North American market for Metronidazole Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metronidazole Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Metronidazole Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Metronidazole Injection include Pfizer, B. Braun Medical Inc, Sanofi-Aventis Canada Inc, Baxter, JB Chemicals and Pharmaceuticals, Qatar Pharma, Unique Pharmaceuticals, Sagent Pharmaceuticals and AdvaCare Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Metronidazole Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metronidazole Injection by region & country, by Type, and by Application.
The Metronidazole Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metronidazole Injection.
Market Segmentation
By Company
Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma
Segment by Type:
500mg/100mL
50mg/10mL
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metronidazole Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Metronidazole Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Metronidazole Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Metronidazole Injection Product Introduction
1.2 Global Metronidazole Injection Market Size Forecast
1.2.1 Global Metronidazole Injection Sales Value (2019-2030)
1.2.2 Global Metronidazole Injection Sales Volume (2019-2030)
1.2.3 Global Metronidazole Injection Sales Price (2019-2030)
1.3 Metronidazole Injection Market Trends & Drivers
1.3.1 Metronidazole Injection Industry Trends
1.3.2 Metronidazole Injection Market Drivers & Opportunity
1.3.3 Metronidazole Injection Market Challenges
1.3.4 Metronidazole Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Metronidazole Injection Players Revenue Ranking (2023)
2.2 Global Metronidazole Injection Revenue by Company (2019-2024)
2.3 Global Metronidazole Injection Players Sales Volume Ranking (2023)
2.4 Global Metronidazole Injection Sales Volume by Company Players (2019-2024)
2.5 Global Metronidazole Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers Metronidazole Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Metronidazole Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Metronidazole Injection
2.9 Metronidazole Injection Market Competitive Analysis
2.9.1 Metronidazole Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Metronidazole Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metronidazole Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 500mg/100mL
3.1.2 50mg/10mL
3.2 Global Metronidazole Injection Sales Value by Type
3.2.1 Global Metronidazole Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Metronidazole Injection Sales Value, by Type (2019-2030)
3.2.3 Global Metronidazole Injection Sales Value, by Type (%) (2019-2030)
3.3 Global Metronidazole Injection Sales Volume by Type
3.3.1 Global Metronidazole Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Metronidazole Injection Sales Volume, by Type (2019-2030)
3.3.3 Global Metronidazole Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global Metronidazole Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adult Use
4.1.2 Pediatric Use
4.1.3 Geriatric Use
4.2 Global Metronidazole Injection Sales Value by Application
4.2.1 Global Metronidazole Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Metronidazole Injection Sales Value, by Application (2019-2030)
4.2.3 Global Metronidazole Injection Sales Value, by Application (%) (2019-2030)
4.3 Global Metronidazole Injection Sales Volume by Application
4.3.1 Global Metronidazole Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Metronidazole Injection Sales Volume, by Application (2019-2030)
4.3.3 Global Metronidazole Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global Metronidazole Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Metronidazole Injection Sales Value by Region
5.1.1 Global Metronidazole Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Metronidazole Injection Sales Value by Region (2019-2024)
5.1.3 Global Metronidazole Injection Sales Value by Region (2025-2030)
5.1.4 Global Metronidazole Injection Sales Value by Region (%), (2019-2030)
5.2 Global Metronidazole Injection Sales Volume by Region
5.2.1 Global Metronidazole Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Metronidazole Injection Sales Volume by Region (2019-2024)
5.2.3 Global Metronidazole Injection Sales Volume by Region (2025-2030)
5.2.4 Global Metronidazole Injection Sales Volume by Region (%), (2019-2030)
5.3 Global Metronidazole Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Metronidazole Injection Sales Value, 2019-2030
5.4.2 North America Metronidazole Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Metronidazole Injection Sales Value, 2019-2030
5.5.2 Europe Metronidazole Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Metronidazole Injection Sales Value, 2019-2030
5.6.2 Asia Pacific Metronidazole Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Metronidazole Injection Sales Value, 2019-2030
5.7.2 South America Metronidazole Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Metronidazole Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa Metronidazole Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Metronidazole Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Metronidazole Injection Sales Value
6.2.1 Key Countries/Regions Metronidazole Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions Metronidazole Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Metronidazole Injection Sales Value, 2019-2030
6.3.2 United States Metronidazole Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Metronidazole Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Metronidazole Injection Sales Value, 2019-2030
6.4.2 Europe Metronidazole Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Metronidazole Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Metronidazole Injection Sales Value, 2019-2030
6.5.2 China Metronidazole Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Metronidazole Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Metronidazole Injection Sales Value, 2019-2030
6.6.2 Japan Metronidazole Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Metronidazole Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Metronidazole Injection Sales Value, 2019-2030
6.7.2 South Korea Metronidazole Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Metronidazole Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Metronidazole Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Metronidazole Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Metronidazole Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Metronidazole Injection Sales Value, 2019-2030
6.9.2 India Metronidazole Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Metronidazole Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Metronidazole Injection Product Offerings
7.1.5 Pfizer Recent Development
7.2 B. Braun Medical Inc
7.2.1 B. Braun Medical Inc Company Information
7.2.2 B. Braun Medical Inc Introduction and Business Overview
7.2.3 B. Braun Medical Inc Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 B. Braun Medical Inc Metronidazole Injection Product Offerings
7.2.5 B. Braun Medical Inc Recent Development
7.3 Sanofi-Aventis Canada Inc
7.3.1 Sanofi-Aventis Canada Inc Company Information
7.3.2 Sanofi-Aventis Canada Inc Introduction and Business Overview
7.3.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Offerings
7.3.5 Sanofi-Aventis Canada Inc Recent Development
7.4 Baxter
7.4.1 Baxter Company Information
7.4.2 Baxter Introduction and Business Overview
7.4.3 Baxter Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Baxter Metronidazole Injection Product Offerings
7.4.5 Baxter Recent Development
7.5 JB Chemicals and Pharmaceuticals
7.5.1 JB Chemicals and Pharmaceuticals Company Information
7.5.2 JB Chemicals and Pharmaceuticals Introduction and Business Overview
7.5.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Offerings
7.5.5 JB Chemicals and Pharmaceuticals Recent Development
7.6 Qatar Pharma
7.6.1 Qatar Pharma Company Information
7.6.2 Qatar Pharma Introduction and Business Overview
7.6.3 Qatar Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Qatar Pharma Metronidazole Injection Product Offerings
7.6.5 Qatar Pharma Recent Development
7.7 Unique Pharmaceuticals
7.7.1 Unique Pharmaceuticals Company Information
7.7.2 Unique Pharmaceuticals Introduction and Business Overview
7.7.3 Unique Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Unique Pharmaceuticals Metronidazole Injection Product Offerings
7.7.5 Unique Pharmaceuticals Recent Development
7.8 Sagent Pharmaceuticals
7.8.1 Sagent Pharmaceuticals Company Information
7.8.2 Sagent Pharmaceuticals Introduction and Business Overview
7.8.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sagent Pharmaceuticals Metronidazole Injection Product Offerings
7.8.5 Sagent Pharmaceuticals Recent Development
7.9 AdvaCare Pharma
7.9.1 AdvaCare Pharma Company Information
7.9.2 AdvaCare Pharma Introduction and Business Overview
7.9.3 AdvaCare Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
7.9.4 AdvaCare Pharma Metronidazole Injection Product Offerings
7.9.5 AdvaCare Pharma Recent Development
8 Industry Chain Analysis
8.1 Metronidazole Injection Industrial Chain
8.2 Metronidazole Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Metronidazole Injection Sales Model
8.5.2 Sales Channel
8.5.3 Metronidazole Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂